Company Profile
Kyverna Therapeutics Stock Price, News & Analysis
- Ticker:
- KYTX
- Exchange:
- NASDAQ
- Sector:
- Biotechnology
- Location:
- Headquartered in the United States and listed on NASDAQ, Kyverna Therapeutics is followed within the RNA therapeutics universe for its exposure to platform execution and clinical milestones.
Stock performance
8.43 USD (+1.57%)
Close
Last updated: June 23, 2026 at 00:00
512.5M USD
Market cap
Why the stock is moving
KYTX is trading with a steady catalyst profile while investors wait for the next headline that changes the story.
Company overview
Business overview
Kyverna Therapeutics is an RNA medicines company focused on using nucleic-acid based approaches to address disease at the source. Investors usually watch platform progress, clinical translation, and whether the company can convert molecular science into a broader pipeline.
Geographic Base and Sector Classification
Headquartered in the United States and listed on NASDAQ, Kyverna Therapeutics is followed within the RNA therapeutics universe for its exposure to platform execution and clinical milestones.
Business Model Characteristics
Kyverna Therapeutics is a platform-led model built around RNA-based programs, so investors focus on readouts, delivery, and how efficiently the company can advance each new candidate through the clinic.
Position Within the Biotechnology Landscape
Compared with more diversified peers, Kyverna Therapeutics sits on the catalyst-driven side of the biotech landscape, where RNA platform momentum can move the stock quickly.
Future catalysts
Recent news
The five most recent feed items are shown below in reverse chronological order.
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of Kyverna Therapeutics (KYTX)?
Kyverna Therapeutics (KYTX) most recently closed at 8.43 USD, a +1.57% move versus the previous session.
What is the market cap of Kyverna Therapeutics (KYTX)?
Kyverna Therapeutics currently has a market capitalization of 512.5M USD on BioPharmSignal.
What does Kyverna Therapeutics do?
Kyverna Therapeutics is an RNA medicines company focused on using nucleic-acid based approaches to address disease at the source. Investors usually watch platform progress, clinical translation, and whether the company can convert molecular science into a broader pipeline.
On which exchange is KYTX stock listed?
Kyverna Therapeutics (KYTX) is associated with NASDAQ, Headquartered in the United States and listed on NASDAQ, Kyverna Therapeutics is followed within the RNA therapeutics universe for its exposure to platform execution and clinical milestones., Biotechnology.
What is Kyverna?
Kyverna Therapeutics is an RNA medicines company focused on using nucleic-acid based approaches to address disease at the source.
Which conditions is Kyverna Therapeutics targeting with Kyverna?
Kyverna Therapeutics is an RNA medicines company focused on using nucleic-acid based approaches to address disease at the source. Investors usually watch platform progress, clinical translation, and whether the company can convert molecular science into a broader pipeline.
What is Therapeutics?
Kyverna Therapeutics is an RNA medicines company focused on using nucleic-acid based approaches to address disease at the source.
What is Investors?
Investors usually watch platform progress, clinical translation, and whether the company can convert molecular science into a broader pipeline.